Predictive value of both irisin and apelin for heart failure with preserved ejection fraction in type 2 diabetes mellitus patients
| dc.contributor.author | Berezin, A. E. | |
| dc.contributor.author | Fushtei, I. M. | |
| dc.contributor.author | Berezin, A. A. | |
| dc.contributor.author | Березін, Олександр Євгенійович | |
| dc.date.accessioned | 2022-06-15T13:33:01Z | |
| dc.date.available | 2022-06-15T13:33:01Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Irisin is skeletal muscle-derived peptide, the expression of which is under close control of peroxisome proliferator-activated receptor-γ co-activator 1α. Apelin is a peptide having positive inotrope ability and acting as an autocrine regulator of cardiac and vascular reparation. Type 2 diabetes mellitus (T2DM). The aim of the study was to investigate whether serum levels of both irisin and apelin predict HF with preserved ejection fraction (HFpEF) in patients with T2DM. | uk_UK |
| dc.identifier.citation | Berezin A. Predictive value of both irisin and apelin for heart failure with preserved ejection fraction in type 2 diabetes mellitus patients / A. Berezin, I. M. Fushtei, A. A. Berezin // European Journal of Preventive Cardiology. – 2022. – Vol. 29, Suppl. 1. – zwac056.016. https://doi.org/10.1093/eurjpc/zwac056.016 | uk_UK |
| dc.identifier.issn | 2047-4873 | |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/16947 | |
| dc.language.iso | en | uk_UK |
| dc.subject | hemodynamics | uk_UK |
| dc.subject | echocardiography | uk_UK |
| dc.subject | informed consent | uk_UK |
| dc.subject | enzyme-linked immunosorbent assay | uk_UK |
| dc.title | Predictive value of both irisin and apelin for heart failure with preserved ejection fraction in type 2 diabetes mellitus patients | uk_UK |
| dc.type | Article | uk_UK |